Hemodynamic effects of treatment with the ketone body 3-hydroxybutyrate in cardiogenic shock - a randomized, controlled, assessor-blinded porcine trial

8 March 2024 (08:30 - 13:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Oskar Kjaergaard Horsdal

Aarhus University Hospital, Aarhus N (Denmark)

6 More presentations in this session

Presentation thumbnail

Vasodilators for acute heart failure. A systematic review of randomized clinical trials with meta-analysis and trial sequential analysis

Miss N. Olsen El Caidi (Hvidovre, DK)

Abstract Slides

Presentation thumbnail

An association between early rescue left heart unloading during VA-ECMO treatment and prognosis of cardiogenic shock; the post-hoc study of the EARLY-UNLOAD trial.

Doctor Y. Lim (Gwangju, KR)

Abstract Slides

Presentation thumbnail

Global longitudinal strain as a predictor of mortality in patients with cardiogenic shock

Mr K. Berg-Hansen (Aarhus, DK)

Abstract Slides

Presentation thumbnail

Exploring the utility of the CSWG SCAI classification in patients with HF-CS requiring inotropic therapy

Mr T. Ris (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Clinical characteristics and outcome of non-acute myocardial syndrome cardiogenic shock in comparison to its ischaemic aetiology

Doctor M. Sokolski (Wroclaw, PL)

Abstract Slides

Access the full session

Session thumbnail

Cardiogenic shock

The Event

Event poster

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

You may be interested in

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

Congress Session

Devices in acute heart failure

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources